Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $50 Million - $60 Million
-4,438,000 Reduced 29.13%
10,798,000 $129 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $90.2 Million - $112 Million
10,287,000 Added 207.86%
15,236,000 $165 Million
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $27.5 Million - $32.6 Million
-2,872,000 Reduced 36.72%
4,949,000 $48.8 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $70.5 Million - $80.5 Million
7,821,000 New
7,821,000 $78.1 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $143 Million - $174 Million
-11,835,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $169 Million - $222 Million
11,835,000 New
11,835,000 $222 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Slate Path Capital LP Portfolio

Follow Slate Path Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Path Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Slate Path Capital LP with notifications on news.